முள்ளந்தண்டு எலும்பு பாதிக்கப்பட்டு உணர்ச்சியை இழந்து தவிக்கும்
நோயாளிக்கு சிகிச்சை அளிக்கக்கூடிய வகையில் பயோனிக் முள்ளந்துண்டு
செயற்கையாக உருவாக்கப்பட்டுள்ளது.
அவுஸ்திரேலியாவின் மெல்போர்ன் பல்கலைக்கழகத்தைச் சேர்ந்த
ஆராய்ச்சியாளர்களால் உருவாக்கப்பட்ட இந்த முள்ளத்தண்டினை இரத்த
நாளங்களுக்கு இடையில் பொருத்த முடிவதுடன் மூளைக்கு இலத்திரனியல் சமிக்ஞைகளை
கடத்தக்கூடியதாகவும் காணப்படுகின்றது.
3 சென்றி மீற்றர்கள் நீளமான இந்த முள்ளந்தண்டினை நோயாளியின் கழுத்துப்
பகுதியில் சத்திரசிகிச்சையினை மேற்கொள்வதன் மூலம் பொருத்த முடியும் என
தெரிவிக்கப்பட்டுள்ளது.
இதன் மூலம் உணர்ச்சிகளை அறிய முடிவதுடன், இயக்கத்திற்கு தேவையான
சமிக்ஞைகளை கடத்தக்கூடியதாகவும் இருக்கும் எனவும், 2017ம் ஆண்டு முதல் இந்த
பயோனிக் முதுகெலும்பு பயன்படுத்தி சத்திரசிகிச்சை மேற்கொள்ளும்
மருத்துவமுறை அறிமுகமாகும் எனவும் மேலும் குறிப்பிடப்பட்டுள்ளது.
Paralysed patients may be able to walk again using the power of thought after scientists developed the world's first 'bionic spinal cord'. The
discovery, which involves inserting an implant about the size of a
small paperclip into the brain to control an exoskeleton or prosthetic
limbs, has been hailed as the 'holy grail' in bionics. It works
by decoding brain activity responsible for movement - training a
computer to recognise those signatures and then activating robotic limbs
when these are registered. The device - an electrode called the
'stentrode' - is fitted with a tube without the need for risky open
surgery. Human trials are to be carried out on three people next year. It
reads electrical signals from the motor cortex - the brain's control
centre. These can then be transmitted to an exoskeleton or wheelchair to
give paraplegics greater mobility.
University of Melbourne - Pursuit
Holy grail: The device will allow the paralysed to walk through the power of thought
University of Melbourne - Pursuit
Radical: The discovery involved inserting a small implant into the brain
Over time, it's believed it will become second nature - like driving or playing the piano.
The device records neural activity that has been shown in pre-clinical trials to move limbs through an exoskeleton.
The
first participants will be selected from the Austin Health Victorian
Spinal Cord Unit in Australia and fitted with the stentrode at The Royal
Melbourne Hospital in 2017.
Described in the journal Nature Biotechnology, it's capable of recording high-quality signals emitted from the motor cortex.
Dr Thomas Oxley, a neurologist at The Royal Melbourne Hospital, said the stentrode was revolutionary.
He
said: "We've been able to create the world's only minimally invasive
device that is implanted into a blood vessel in the brain via a simple
day procedure - avoiding the need for high risk open brain surgery.
"Our
vision - through this device - is to return function and mobility to
patients with complete paralysis by recording brain activity and
converting the acquired signals into electrical commands which in turn
would lead to movement of the limbs through a mobility assist device
like an exoskeleton.
"In essence this a bionic spinal cord."
University of Melbourne - Pursuit
Device: It records brain activity and uses it to work an exoskeleton
Stroke and spinal cord injuries are leading causes of disability affecting 1 in 50 people.
Dr
Nicholas Opie, of Melbourne University, said the concept was similar to
an implantable cardiac pacemaker - electrical interaction with tissue
using sensors inserted into a vein but inside the brain.
He said:
"Utilising stent technology our electrode array self-expands to stick
to the inside wall of a vein enabling us to record local brain activity.
"By
extracting the recorded neural signals we can use these as commands to
control wheelchairs, exoskeletons, prosthetic limbs or computers.
"In
our first-in-human trial - that we anticipate will begin within two
years - we are hoping to achieve direct brain control of an exoskeleton
for three people with paralysis.
"Currently exoskeletons are
controlled by manual manipulation of a joystick to switch between the
various elements of walking - stand, start, stop, turn. The stentrode
will be the first device that enables direct thought control of these
devices."
University of Melbourne - Pursuit
Implant: The new development is considered a major breakthrough
Prof Clive May, of Melbourne University, said the data from
the pre-clinical study highlighted the implantation of the device was
safe for long-term use.
He said: "Through our pre-clinical study
we were able to successfully record brain activity over many months. The
quality of recording improved as the device was incorporated into
tissue.
"Our study also showed it was safe and effective to
implant the device via angiography which is minimally invasive compared
with the high risks associated with open brain surgery.
"The
brain-computer interface is a revolutionary device that holds the
potential to overcome paralysis, by returning mobility and independence
to patients affected by various conditions."
Prof Terry O'Brien, of The Royal Melbourne Hospital, said the stentrode is the "holy grail" for research in bionics.
University of Melbourne - Pursuit
Groundbreaking: It could also work with diseases like Parkinsons or strokes
He said: "To be able to create a device that can record
brainwave activity over long periods of time without damaging the brain
is an amazing development in modern medicine.
"It can also be
potentially used in people with a range of diseases aside from spinal
cord injury including epilepsy, Parkinsons and other neurological
disorders."
There is currently no treatment for spinal cord injury right now, only rehab.
கருத்துரையிடுக Facebook Disqus